1Ross R. Atherosclerosis an inflammatory disease[J]. N Engl J Med,1999,340(2) :115.
2Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor kappa B is present in the atherosclerotic lesion[J]. J Clin Invest,1996,97(7) :1715-1722.
3Muler WA, Randolph GJ. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocyte[J]. J Leukoc Boil, 1999,66(5):698- 704.
4Link A, Bohm M, Nickenung G. Acute coronary syndrome-better risk stratification by determination of inflammation parameters[J] ? Med Klin, 2002,97 (2) : 63-69.
5Bermudez EA, Ridker PM. C reactive protein, statins, and the primary prevention of atheroselerotic cardiovascular disease[J]. Preventive Cadiology,2002,5(1):42-46.
6Onno J, de Boer AC, Peter TL, et al. Leucocyte recruitment in rupture prone regions of lipid rich plaques, a prominent role for neovaseularization [ J ]. Cardiovascular Research,1999,41(3) :443- 449.
8Ridker PM, Hennens CH, Bring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J]. N Engl Med, 2000,342(12) :836-843.
9Ridker PM, Rafai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently health men [J ].Circulation, 2000,101(15) : 1767-1772.
10Alter P, Heoschen J, Rilter M, et al. Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves[J].Am J Cardiol,2002,89(12):1400-1404.
二级参考文献24
1Kuvin JT, Kimmelstiel CD. Infectious causes of atherosclerosis. Am Heart J, 1999, 137(2):216~226.
2Strachan DP, Carrington D, Mendall MA, et al. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.BMJ, 1999, 318(7190): 1035 ~ 1039.
3Kaftan AH, Kaftan O. Coronary artery disease and infection with chlamydia pneumonia. Jpn Heart J, 2000, 41(2): 165 ~ 172.
4Sessa R, Di Pietro M, Santino I, et al. Chlamydia pneumoniae infection and atherosclerotic coronary disease. Am Heart J, 1999, 137(6) : 1116 ~ 1119.
5Mehta JL, Saldeen TG, Rand K. et al. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol, 1998, 31(6):1217 ~ 1225.
6Burke AP, Tracy RP, Kolodgie F, et al. Elevated C-reactive protein values and atheroscleresis in sudden coronary death : association with different pathologies. Circulation, 2002, 105(17): 2019-2023.
7Gupta S. Chronic infection in the aetiolosy of atheroeclerosis-focus on Chlamydia pneumoniae. Atherosclerosis, 1999, 143 (1) : 1 ~ 6.
8Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes: implications for plaque. Circulation. 1994, 90:775.
9Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993, 362:801.
10Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med.1999,340:115.
